Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by macman1519on Jan 30, 2018 6:38pm
43 Views
Post# 27466664

RE:RE:RE:RE:RE:NMIBC Ph. 1b trial shows up first in Canadian Cancer Trials

RE:RE:RE:RE:RE:NMIBC Ph. 1b trial shows up first in Canadian Cancer Trials Ahhh, ya, i want a pat on the back, ive been saying the same thing for months!!! And ive always said, why hasnt Roger said that once since Nov 8 to us??? Why is it up to u and others here to drum up interest and to show how great our results really are??? As for who is responsible for our sp???? Warrants, manipulators, day traders, all the things that will increase with a pp, and disappear, to dramatically decrease with pharma on board!!! Cmon lemmings u still havent answered my question, ur just like the crickets! THINK FOR URSELF! U HAVE A MIND, HUMANS ARE SUCCESSFUL BECAUSE THE IDENTIFY PATTERNS, MAKE SENSE OF THEIR ENVIRONMENT, DEDUCE AND CONCLUDE! BE HUMAN, Think!!
Eoganacht wrote: Does anyone know a cancer treatment that brings about the complete destruction of cancer permanently after one treatment? Why should Theralase be expected to produce that result in their safety trial?

We got very good results - 90 days non-recurrence, 180 days non-progression in 3 out of 3 low dose patients with no significant adverse affects. Our stock lost half it's value for no rational reason.

In our efficacy trial we will be able to administer several treatments to a single patient, the immune effect should kick in and we should see a substantial number of complete responses.

jojomarch wrote: The way I see it is that P1-4 have passed safety and tolerability. P1-3 had recurrence at 180 days but chances are the recurring cells never absorbed the compound therefore were not destroyed when initially treated . Now P4 has received double the dose than the first three patients now we wait for the public release ( interpretation ) of the results for 180 days . Maybe the double dose was the key for success if so the stock market and big pharma will react . GLTA




Bullboard Posts